
2.92 BATS BZX Real-Time Price As of 1:56pm ET | ![]() Today’s Change | 2.66 Today|||52-Week Range 10.01 | -11.13% Year-to-Date |
Atara Biotherapeutics (ATRA) Loses -33.02% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Mar 24 / Zacks.com - Paid Partner Content | Karuna's (KRTX) KarXT Meets Primary Goal in Schizophrenia Study Mar 21 / Zacks.com - Paid Partner Content |
89bio (ETNB) Up 25% on Upbeat Data From Mid-Stage NASH Study Mar 23 / Zacks.com - Paid Partner Content | Esperion (ESPR) Plummets 54% Over Milestone Payment Row Mar 17 / Zacks.com - Paid Partner Content |
Sanofi's (SNY) Dupixent Meets Goal in Pivotal COPD Study Mar 23 / Zacks.com - Paid Partner Content | Merck's (MRK) Co-formulation Therapy Fails Lung Cancer Study Mar 17 / Zacks.com - Paid Partner Content |
Previous close | 2.98 |
Today’s open | 2.96 |
Day’s range | 2.92 - 2.99 |
Volume | 11,723 |
Average volume (3 months) | 1,313,824 |
Market cap | $275.3M |
Earnings growth (last year) | +38.36% |
Earnings growth (this year) | +8.94% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | +212.55% |
P/E ratio | NM |
Price/Sales | 5.26 |
Price/Book | 2.16 |
Next reporting date | May 10, 2023 |
EPS forecast (this quarter) | -$0.37 |
Annual revenue (last year) | $63.6M |
Annual profit (last year) | -$228.3M |
Net profit margin | -359.12% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Thousand Oaks, California |